Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the net profit margin high or low?
The net profit margin of 16.40% is in line with its 5-year average of 17.76%, around the middle of its 5-year range (-5.58%–33.21%).
As of the fiscal period ended Tuesday, March 31, 2026. 85.74% above its 12-month average of 8.83%.
Reported quarterly profit margin; no daily interpolation.
NET PROFIT MARGIN
16.40%
NET PROFIT MARGIN AVG TTM
8.83%
NET PROFIT MARGIN AVG 3Y
13.10%
NET PROFIT MARGIN AVG 5Y
17.76%
NET PROFIT MARGIN AVG 10Y
17.33%
NET PROFIT MARGIN AVG 15Y
21.59%
NET PROFIT MARGIN AVG 20Y
26.51%
CURRENT VS TTM AVG
+85.74%
CURRENT VS 3Y AVG
+25.17%
CURRENT VS 5Y AVG
-7.67%
CURRENT VS 10Y AVG
-5.37%
CURRENT VS 15Y AVG
-24.06%
CURRENT VS 20Y AVG
-38.15%
SECTOR MEDIAN · HEALTHCARE
8.91%
median of 76 covered companies
CURRENT VS SECTOR MEDIAN
+84.01%
vs the sector median at left
Bio-Techne Corporation
Market Cap
$11.30B
Net Profit Margin
16.40%
TTM Avg
8.83%
3Y Avg
13.10%
5Y Avg
17.76%
Market Cap
$10.21B
Net Profit Margin
8.42%
TTM Avg
7.89%
3Y Avg
6.46%
5Y Avg
6.98%
Market Cap
$12.39B
Net Profit Margin
9.99%
TTM Avg
10.36%
3Y Avg
10.48%
5Y Avg
22.21%
Market Cap
$10.16B
Net Profit Margin
2.95%
TTM Avg
3.05%
3Y Avg
3.43%
5Y Avg
3.79%
Market Cap
$10.15B
Net Profit Margin
-0.02%
TTM Avg
1.97%
3Y Avg
2.41%
5Y Avg
2.58%
Market Cap
$10.02B
Net Profit Margin
12.29%
TTM Avg
14.66%
3Y Avg
10.46%
5Y Avg
7.35%
Market Cap
$9.76B
Net Profit Margin
-17.77%
TTM Avg
-60.53%
3Y Avg
-62.93%
5Y Avg
-77.31%
| NAME | MARKET CAP | NET PROFIT MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Bio-Techne Corporation (TECH) | $11.30B | 16.40% | 8.83% | 13.10% | 17.76% |
| DaVita Inc. (DVA)vs › | $11.45B | 6.05% | 6.39% | 5.83% | 6.41% |
| Universal Health Services, Inc. (UHS)vs › | $10.21B | 8.42% | 7.89% | 6.46% | 6.98% |
| Align Technology, Inc. (ALGN)vs › | $12.39B | 9.99% | 10.36% | 10.48% | 22.21% |
| Henry Schein, Inc. (HSIC)vs › | $10.16B | 2.95% | 3.05% | 3.43% | 3.79% |
| Molina Healthcare, Inc. (MOH)vs › | $10.15B | -0.02% | 1.97% | 2.41% | 2.58% |
| Insulet Corp. (PODD)vs › | $10.02B | 12.29% | 14.66% | 10.46% | 7.35% |
| Tempus AI, Inc. (TEM)vs › | $9.76B | -17.77% | -60.53% | -62.93% | -77.31% |
| Revvity, Inc. (RVTY)vs › | $12.90B | 8.16% | 9.60% | 8.02% | 12.66% |
| Bio-Rad Laboratories, Inc. (BIO)vs › | $9.59B | 8.59% | -21.22% | -48.94% | 16.61% |
Operating Margin
12.7%
Net Profit Margin
16.4%
Net Profit Margin = Net Income / Revenue
Net profit margin is the percentage of revenue that becomes net income after all expenses, taxes, and interest.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | NET PROFIT MARGIN |
|---|---|
| 2026-03-31 | 16.40% |
| 2025-12-31 | 12.85% |
| 2025-09-30 | 13.33% |
| 2025-06-30 | -5.58% |
| 2025-03-31 | 7.14% |
| 2024-12-31 | 11.75% |
| 2024-09-30 | 11.61% |
| 2024-06-30 | 13.26% |
| 2024-03-31 | 16.17% |
| 2023-12-31 | 10.08% |
| 2023-09-30 | 18.41% |
| 2023-06-30 | 25.05% |
| 2023-03-31 | 23.87% |
| 2022-12-31 | 18.41% |
| 2022-09-30 | 33.21% |
| 2022-06-30 | 21.35% |
| 2022-03-31 | 20.92% |
| 2021-12-31 | 29.77% |
| 2021-09-30 | 27.01% |
| 2021-06-30 | 5.78% |
| 2021-03-31 | 18.80% |
| 2020-12-31 | 20.63% |
| 2020-09-30 | 16.35% |
| 2020-06-30 | 33.47% |
| 2020-03-31 | 18.71% |
| 2019-12-31 | 64.68% |
| 2019-09-30 | 7.86% |
| 2019-06-30 | 8.59% |
| 2019-03-31 | 24.16% |
| 2018-12-31 | 10.06% |
| 2018-09-30 | 10.68% |
| 2018-06-30 | 22.69% |
| 2018-03-31 | 12.04% |
| 2017-12-31 | 31.69% |
| 2017-09-30 | 10.97% |
| 2017-06-30 | 18.40% |
| 2017-03-31 | 14.85% |
| 2016-12-31 | 4.79% |
| 2016-09-30 | 12.47% |
| 2016-06-30 | 19.02% |
| 2016-03-31 | 23.13% |
| 2015-12-31 | 21.38% |
| 2015-09-30 | 20.21% |
| 2015-06-30 | 22.38% |
| 2015-03-31 | 21.28% |
| 2014-12-31 | 29.66% |
| 2014-09-30 | 22.04% |
| 2014-06-30 | 28.99% |
| 2014-03-31 | 33.11% |
| 2013-12-31 | 29.82% |
| 2013-09-30 | 32.02% |
| 2013-06-30 | 35.75% |
| 2013-03-31 | 40.89% |
| 2012-12-31 | 33.78% |
| 2012-09-30 | 34.21% |
| 2012-06-30 | 34.62% |
| 2012-03-31 | 37.98% |
| 2011-12-31 | 34.57% |
| 2011-09-30 | 35.47% |
| 2011-06-30 | 36.30% |
| 2011-03-31 | 40.73% |
| 2010-12-31 | 39.19% |
| 2010-09-30 | 38.82% |
| 2010-06-30 | 38.81% |
| 2010-03-31 | 46.09% |
| 2009-12-31 | 37.73% |
| 2009-09-30 | 40.24% |
| 2009-06-30 | 39.12% |
| 2009-03-31 | 40.73% |
| 2008-12-31 | 38.18% |
| 2008-09-30 | 41.25% |
| 2008-06-30 | 40.22% |
| 2008-03-31 | 42.56% |
| 2007-12-31 | 38.04% |
| 2007-09-30 | 39.79% |
| 2007-06-30 | 39.24% |
| 2007-03-31 | 39.69% |
| 2006-12-31 | 35.54% |
| 2006-09-30 | 37.50% |
| 2006-06-30 | 37.43% |
| 2006-03-31 | 37.12% |
| 2005-12-31 | 34.38% |
| 2005-09-30 | 35.63% |
| 2005-06-30 | 39.05% |
| 2005-03-31 | 38.47% |
| 2004-12-31 | 35.35% |
| 2004-09-30 | 34.68% |
| 2004-06-30 | 31.48% |
| 2004-03-31 | 34.36% |
| 2003-12-31 | 32.33% |
| 2003-09-30 | 33.09% |
| 2003-06-30 | 32.15% |
| 2003-03-31 | 32.84% |
| 2002-12-31 | 29.67% |
| 2002-09-30 | 30.23% |
| 2002-06-30 | -0.85% |
